1-4 of 4
Linda A. Snyder
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Niraparib Shows Superior Tissue Distribution and Efficacy in a Prostate Cancer Bone Metastasis Model Compared with Other PARP Inhibitors

Linda A. Snyder, Rajendra Damle, Shefali Patel, Jared Bohrer, Anna Fiorella, Jenny Driscoll, Rebecca Hawkins, Christopher F. Stratton, Carol D. Manning, Kanaka Tatikola, Volha Tryputsen, Kathryn Packman, Rao N.V.S. Mamidi
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (7): 1115–1124.
https://doi.org/10.1158/1535-7163.MCT-21-0798
Published: 05 July 2022
View articletitled, Niraparib Shows Superior Tissue Distribution and Efficacy in a Prostate Cancer Bone Metastasis Model Compared with Other PARP Inhibitors
Open the PDF for Niraparib Shows Superior Tissue Distribution and Efficacy in a Prostate Cancer Bone Metastasis Model Compared with Other PARP Inhibitors in another window
Includes: Supplementary data
Journal Articles

Blocking the CCL2–CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model

Kun-Yu Teng, Jianfeng Han, Xiaoli Zhang, Shu-Hao Hsu, Shun He, Nissar A. Wani, Juan M. Barajas, Linda A. Snyder, Wendy L. Frankel, Michael A. Caligiuri, Samson T. Jacob, Jianhua Yu, Kalpana Ghoshal
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (2): 312–322.
https://doi.org/10.1158/1535-7163.MCT-16-0124
Published: 02 February 2017
View articletitled, Blocking the CCL2–CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model
Open the PDF for Blocking the CCL2–CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model in another window
Includes: Supplementary data
Journal Articles

Abstract A190: Colon tumor cells expressing CD24 have oncogenic properties and are inhibited by monoclonal antibody immunotherapy.

Luciana F. Macedo, Elizabeth Kaiser, Haiyan Jiang, Hillary Millar, Diana Wiley, Adam Cotty, Fred Kaplan, Barry Morse, Jill M. Carton, Michael F. Naso, Randall Brezski, Allison Oberholtze, E. Christine Pietsch, Li Yingzhe, Debbie Marshall, Linda A. Snyder
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A190.
https://doi.org/10.1158/1535-7163.TARG-13-A190
Published: 01 November 2013
View articletitled, Abstract A190: Colon tumor cells expressing CD24 have oncogenic properties and are inhibited by monoclonal antibody immunotherapy.
Journal Articles

Abstract C189: CD24 plays an important role on NSCLC cell functions relevant to tumor growth.

Luciana F. Macedo, Elizabeth Kaiser, Haiyan Jiang, Hillary Millar, E. Christine Pietsch, Fred Kaplan, Diana Wiley, Linda A. Snyder, Debbie Marshall
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): C189.
https://doi.org/10.1158/1535-7163.TARG-13-C189
Published: 01 November 2013
View articletitled, Abstract C189: CD24 plays an important role on NSCLC cell functions relevant to tumor growth.